Maternal cannabis use disorder linked to higher autism risk in children, study finds

FHS
May 23, 2024
8:26 pm

A study in Psychiatry Research reveals that maternal cannabis use disorder significantly increases the risk of autism spectrum disorder (ASD) in offspring. The risk is 3.5 times higher for children exposed to cannabis during the prenatal period.

Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies

When Sanjaya Singh left Johnson & Johnson in 2021, his former colleague Peter Lebowitz paid close attention. Singh had been a mainstay in the immunology

July 23, 2024

Amgen closes $28B Horizon acquisition a month after FTC battle ended

Amgen has sealed its high-profile $27.8 billion pursuit of Horizon Therapeutics, closing the deal after a lengthy 10-month acquisition process in which the Federal Trade

October 7, 2023

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY NEGEV CAPITAL – Psychedelic Alpha

VANCOUVER, BC, Sept. 29, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE:7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company,

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.